277 related articles for article (PubMed ID: 25804706)
1. Bacterial phospholipases C as vaccine candidate antigens against cystic fibrosis respiratory pathogens: the Mycobacterium abscessus model.
Le Moigne V; Rottman M; Goulard C; Barteau B; Poncin I; Soismier N; Canaan S; Pitard B; Gaillard JL; Herrmann JL
Vaccine; 2015 Apr; 33(18):2118-24. PubMed ID: 25804706
[TBL] [Abstract][Full Text] [Related]
2. MgtC as a Host-Induced Factor and Vaccine Candidate against Mycobacterium abscessus Infection.
Le Moigne V; Belon C; Goulard C; Accard G; Bernut A; Pitard B; Gaillard JL; Kremer L; Herrmann JL; Blanc-Potard AB
Infect Immun; 2016 Oct; 84(10):2895-903. PubMed ID: 27481243
[TBL] [Abstract][Full Text] [Related]
3. Vaccine strategies against cystic fibrosis pathogens.
Le Moigne V; Gaillard JL; Herrmann JL
Hum Vaccin Immunother; 2016 Mar; 12(3):751-6. PubMed ID: 26618824
[TBL] [Abstract][Full Text] [Related]
4. Mycobacterium abscessus phospholipase C expression is induced during coculture within amoebae and enhances M. abscessus virulence in mice.
Bakala N'Goma JC; Le Moigne V; Soismier N; Laencina L; Le Chevalier F; Roux AL; Poncin I; Serveau-Avesque C; Rottman M; Gaillard JL; Etienne G; Brosch R; Herrmann JL; Canaan S; Girard-Misguich F
Infect Immun; 2015 Feb; 83(2):780-91. PubMed ID: 25486995
[TBL] [Abstract][Full Text] [Related]
5. A multicenter vaccine trial using the Pseudomonas aeruginosa flagella vaccine IMMUNO in patients with cystic fibrosis.
Döring G; Dorner F
Behring Inst Mitt; 1997 Feb; (98):338-44. PubMed ID: 9382758
[TBL] [Abstract][Full Text] [Related]
6. Reduced Sphingosine in Cystic Fibrosis Increases Susceptibility to
Schnitker F; Liu Y; Keitsch S; Soddemann M; Verhasselt HL; Kehrmann J; Grassmé H; Kamler M; Gulbins E; Wu Y
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762308
[TBL] [Abstract][Full Text] [Related]
7. Specificity of Immunoglobulin Response to Nontuberculous Mycobacteria Infection in People with Cystic Fibrosis.
Malcolm KC; Wheeler EA; Calhoun K; Lenhart-Pendergrass PM; Rysavy N; Poch KR; Caceres SM; Saavedra MT; Nick JA
Microbiol Spectr; 2022 Aug; 10(4):e0187422. PubMed ID: 35863022
[TBL] [Abstract][Full Text] [Related]
8. Relative increase in IgG antibodies to Pseudomonas aeruginosa 60-kDa GroEL in prediabetic patients with cystic fibrosis.
Jensen P; Johansen HK; Lanng S; Høiby N
Pediatr Res; 2001 Mar; 49(3):423-8. PubMed ID: 11228271
[TBL] [Abstract][Full Text] [Related]
9. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.
Ciofu O
APMIS Suppl; 2003; (116):1-47. PubMed ID: 14692154
[TBL] [Abstract][Full Text] [Related]
10. IgA Serological Response for the Diagnosis of Mycobacterium abscessus Infections in Patients with Cystic Fibrosis.
Le Moigne V; Roux AL; Mahoudo H; Christien G; Ferroni A; Dumitrescu O; Lina G; Bouchara JP; Plésiat P; Gaillard JL; Canaan S; Héry-Arnaud G; Herrmann JL
Microbiol Spectr; 2022 Jun; 10(3):e0019222. PubMed ID: 35583329
[TBL] [Abstract][Full Text] [Related]
11. Non-Tuberculous Mycobacteria multispecies biofilms in cystic fibrosis: development of an in vitro Mycobacterium abscessus and Pseudomonas aeruginosa dual species biofilm model.
Rodríguez-Sevilla G; García-Coca M; Romera-García D; Aguilera-Correa JJ; Mahíllo-Fernández I; Esteban J; Pérez-Jorge C
Int J Med Microbiol; 2018 Apr; 308(3):413-423. PubMed ID: 29555180
[TBL] [Abstract][Full Text] [Related]
12. Immunological evaluation of an alginate-based conjugate as a vaccine candidate against Pseudomonas aeruginosa.
Farjah A; Owlia P; Siadat SD; Mousavi SF; Ardestani MS; Mohammadpour HK
APMIS; 2015 Feb; 123(2):175-83. PubMed ID: 25470757
[TBL] [Abstract][Full Text] [Related]
13. Combined Host- and Pathogen-Directed Therapy for the Control of Mycobacterium abscessus Infection.
Poerio N; Riva C; Olimpieri T; Rossi M; Lorè NI; De Santis F; Henrici De Angelis L; Ciciriello F; D'Andrea MM; Lucidi V; Cirillo DM; Fraziano M
Microbiol Spectr; 2022 Feb; 10(1):e0254621. PubMed ID: 35080463
[TBL] [Abstract][Full Text] [Related]
14. Comparing Mycobacterium massiliense and Mycobacterium abscessus lung infections in cystic fibrosis patients.
Roux AL; Catherinot E; Soismier N; Heym B; Bellis G; Lemonnier L; Chiron R; Fauroux B; Le Bourgeois M; Munck A; Pin I; Sermet I; Gutierrez C; Véziris N; Jarlier V; Cambau E; Herrmann JL; Guillemot D; Gaillard JL;
J Cyst Fibros; 2015 Jan; 14(1):63-9. PubMed ID: 25085077
[TBL] [Abstract][Full Text] [Related]
15. Vaccination promotes TH1-like inflammation and survival in chronic Pseudomonas aeruginosa pneumonia. A new prophylactic principle.
Johansen HK; Cryz SJ; Hougen HP; Moser C; Høiby N
Behring Inst Mitt; 1997 Feb; (98):269-73. PubMed ID: 9382750
[TBL] [Abstract][Full Text] [Related]
16. Rationale for development of immunotherapies that target mucoid Pseudomonas aeruginosa infection in cystic fibrosis patients.
Pier GB
Behring Inst Mitt; 1997 Feb; (98):350-60. PubMed ID: 9382760
[TBL] [Abstract][Full Text] [Related]
17. Antibody responses induced by long-term vaccination with an octovalent conjugate Pseudomonas aeruginosa vaccine in children with cystic fibrosis.
Zuercher AW; Horn MP; Que JU; Ruedeberg A; Schoeni MH; Schaad UB; Marcus P; Lang AB
FEMS Immunol Med Microbiol; 2006 Jul; 47(2):302-8. PubMed ID: 16831219
[TBL] [Abstract][Full Text] [Related]
18. Infection control strategies that successfully controlled an outbreak of Mycobacterium abscessus at a cystic fibrosis center.
Kapnadak SG; Hisert KB; Pottinger PS; Limaye AP; Aitken ML
Am J Infect Control; 2016 Feb; 44(2):154-9. PubMed ID: 26442462
[TBL] [Abstract][Full Text] [Related]
19. Lung transplant outcomes in cystic fibrosis patients with pre-operative Mycobacterium abscessus respiratory infections.
Lobo LJ; Chang LC; Esther CR; Gilligan PH; Tulu Z; Noone PG
Clin Transplant; 2013; 27(4):523-9. PubMed ID: 23710571
[TBL] [Abstract][Full Text] [Related]
20. Affinity constants of naturally acquired and vaccine-induced anti-Pseudomonas aeruginosa antibodies in healthy adults and cystic fibrosis patients.
Bruderer U; Cryz SJ; Schaad UB; Deusinger M; Que JU; Lang AB
J Infect Dis; 1992 Aug; 166(2):344-9. PubMed ID: 1634805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
